Tudor Investment Corp’s Legend Biotech LEGN Stock Holding History

Tudor Investment Corp’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$997K	Buy	55,102 +1,802	+3%	+$34.4K	﹤0.01%	2376
2025 Q4	$1.16M	Buy	53,300 +628	+1%	+$18K	﹤0.01%	2165
2025 Q3	$1.72M	Buy	52,672 +3,167	+6%	+$117K	﹤0.01%	1902
2025 Q2	$1.76M	Sell	49,505 -22,555	-31%	-$731K	﹤0.01%	1745
2025 Q1	$2.44M	Buy	+72,060	New	+$2.58M	0.01%	1200
2024 Q4	–	Sell	-5,572	Closed	-$231K	–	3292
2024 Q3	$272K	Buy	+5,572	New	+$297K	﹤0.01%	2373
2020 Q3	–	Sell	-8,771	Closed	-$373K	–	1435
2020 Q2	$373K	Buy	+8,771	New	+$343K	0.02%	811

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

FBIL

First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Tudor Investment Corp's LEGN Position: Q1 2026 in Review

Tudor Investment Corp increased its Legend Biotech (LEGN) stake by 3.4% in Q1 2026, buying an estimated $34.4K and bringing the position to 55,102 shares worth $997K. The position accounts for ﹤0.01% of the portfolio, ranked #2376.

Tudor Investment Corp first reported a position in LEGN in Q2 2020 and has held it in 7 quarters since. The position peaked at $2.44M in Q1 2025. 190 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

Tudor Investment Corp held 55,102 shares of Legend Biotech worth $997K as of Q1 2026.
Tudor Investment Corp bought 1,802 Legend Biotech shares in Q1 2026, an estimated $34.4K.
Legend Biotech made up ﹤0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #2376 holding.
Tudor Investment Corp first reported a position in Legend Biotech in Q2 2020 and has held it in 7 quarters since.
Tudor Investment Corp's Legend Biotech position peaked at $2.44M in Q1 2025.
190 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.